Dexcom, a leading provider of continuous glucose monitoring (CGM) systems, has issued a Class I recall for several of its receivers due to audio speaker malfunctions. This significant recall is notable as it impacts the safety of users who depend on real-time alerts for managing their blood glucose levels. Since May 2025, there have been 112 complaints globally with 56 related injuries, highlighting the potential severe health implications if users miss alerts or alarms related to dangerously high or low blood sugar levels. These malfunctions can lead to critical health outcomes, such as vomiting, seizures, or loss of consciousness, underscoring the importance of reliable monitoring for individuals with diabetes.
The recall specifically affects certain models of the Dexcom G6, G7, One, and One Plus receivers, the latter two being available outside the United States. As one of the most popular brands of CGM devices, Dexcom plays a pivotal role in the management of diabetes for many individuals. While the company has reassured users that, despite the audio malfunction, alerts can still be received through vibrations and visual prompts, this may not be sufficient. Many users tend to keep their receivers in pockets or bags, which complicates their ability to respond to alerts.
For those using Dexcom CGM devices, immediate action is essential. The CGM system comprises three parts: a glucose sensor, a transmitter, and a receiver, with the current recall focused solely on the latter. Users are advised to check if their device is among those affected by the recall by visiting the Dexcom website to find the model number and serial information located on the receiver’s back. If a device is confirmed as part of the recall, it is crucial to contact Dexcom promptly for a free replacement. The urgent nature of this recall is compounded by the necessity for continuous glucose monitoring, making timely replacement imperative for managing diabetes effectively.
While waiting for a replacement, users should remain vigilant regarding the functionality of the receiver’s speaker. Strategies for this include conducting regular speaker tests whenever the receiver is charged. Upon connecting the device, users should observe the Speaker Test screen’s instructions. A lack of sound during such tests indicates the need to contact Dexcom for assistance. This maintenance check should be part of a broader routine since device malfunctions can occur unpredictably, even for models not currently under recall.
Additionally, Dexcom allows users the option to test their speaker at any time via the device’s menu, ensuring continuous oversight of the device’s performance. For those needing further assistance during this recall, Dexcom’s technical support is accessible through the hotline at 1-844-478-1600. This support is invaluable for ensuring that users maintain effective monitoring during the transition period necessitated by the recall.
In summary, the recall of Dexcom’s CGM receivers is a critical issue for individuals relying on accurate glucose monitoring to manage their diabetes. The health risks associated with malfunctioning devices necessitate urgent attention, including testing and replacement procedures. Dexcom’s efforts to provide replacements and the ongoing support offered through technical assistance highlight the company’s commitment to user safety and effective diabetes management. Timely actions are essential in safeguarding health and ensuring continuous monitoring capability during this period.
